Alpha-Synuclein - What's it all about?

Dr Claudio Ruffmann, Oxford Parkinson's Disease Centre, discusses his research into the protein, Alpha-Synuclein, which is crucial in the pathogenesis of Parkinson's

Why do brain cells die in Parkinson's, and what can we do about it?
▶︎

Why do brain cells die in Parkinson's, and what can we do about it?

Lewy Body Dementia - Synuycleinopathies & Synuclein
▶︎

Lewy Body Dementia - Synuycleinopathies & Synuclein

Pathophysiology of Parkinson's Disease | 2019 Udall Center Research Symposium
▶︎

Pathophysiology of Parkinson's Disease | 2019 Udall Center Research Symposium

Investigating the Contribution of Complement System to Alpha Synuclein and Tau Associated Toxicity
▶︎

Investigating the Contribution of Complement System to Alpha Synuclein and Tau Associated Toxicity

Jeff Bronstein - Parkinson's Disease: An update on what causes it and new treatments
▶︎

Jeff Bronstein - Parkinson's Disease: An update on what causes it and new treatments

Alpha-Synuclein, Neuroinflammation, and More: Emerging Therapies and Parkinson's 2026, Part 4
▶︎

Alpha-Synuclein, Neuroinflammation, and More: Emerging Therapies and Parkinson's 2026, Part 4

An amyloid link between Parkinson’s disease and melanoma
▶︎

An amyloid link between Parkinson’s disease and melanoma

Rapid eye movement sleep behavior disorder (RBD): a window into early Parkinson’s Dr Tom Barber
▶︎

Rapid eye movement sleep behavior disorder (RBD): a window into early Parkinson’s Dr Tom Barber

Webinar: "Primary Parkinson's Protein Alpha-synuclein" November 2016
▶︎

Webinar: "Primary Parkinson's Protein Alpha-synuclein" November 2016

Focused Ultrasound for Parkinson’s Disease and Essential Tremor | Clinical Perspectives
▶︎

Focused Ultrasound for Parkinson’s Disease and Essential Tremor | Clinical Perspectives

Pain and Fatigue in Parkinson Disease - 2019 Parkinson Educational Symposium
▶︎

Pain and Fatigue in Parkinson Disease - 2019 Parkinson Educational Symposium

Alpha-synuclein as a therapeutic target for Parkinson’s disease: challenges and opportunities
▶︎

Alpha-synuclein as a therapeutic target for Parkinson’s disease: challenges and opportunities

Ep. 11 The Chemicals Around Us, Real Causes Of Parkinson's: Dr. Ray Dorsey | This is Parkinson's
▶︎

Ep. 11 The Chemicals Around Us, Real Causes Of Parkinson's: Dr. Ray Dorsey | This is Parkinson's

The Parkinson's You Don't See: Cognitive and Non-motor Symptoms
▶︎

The Parkinson's You Don't See: Cognitive and Non-motor Symptoms

Alpha Synuclein Research in POTS: a New Mechanism?
▶︎

Alpha Synuclein Research in POTS: a New Mechanism?

Interview with Colin Potter - How He Dramatically Improved His Parkinson's Symptom's
▶︎

Interview with Colin Potter - How He Dramatically Improved His Parkinson's Symptom's

Parkinson’s Disease Pathophysiology: A Focus on Alpha-Synuclein
▶︎

Parkinson’s Disease Pathophysiology: A Focus on Alpha-Synuclein

Parkinson's disease "What do successful people do to slow down PD progression?” Dr. Laurie Mischley
▶︎

Parkinson's disease "What do successful people do to slow down PD progression?” Dr. Laurie Mischley

Dr  Anurag Tandon - The spread of alpha synuclein from neuron to neuron HD
▶︎

Dr Anurag Tandon - The spread of alpha synuclein from neuron to neuron HD

Rapsodi Educational Event: The link between GBA mutations, the microbiome and Parkinson disease
▶︎

Rapsodi Educational Event: The link between GBA mutations, the microbiome and Parkinson disease